Toggle Main Menu Toggle Search

Open Access padlockePrints

Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer

Lookup NU author(s): Professor Peter Thomson

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Tobacco and alcohol are major risk factors for upper aerodigestive tract (UADT) cancer and significant variation is observed in UADT cancer rates across Europe. We have estimated the proportion of UADT cancer burden explained by tobacco and alcohol and how this varies with the incidence rates across Europe, cancer sub-site, gender and age. This should help estimate the minimum residual burden of other risk factors to UADT cancer, including human papillomavirus. We analysed 1981 UADT cancer cases and 1993 controls from the ARCAGE multi-centre study. We estimated the population attributable risk (PAR) of tobacco alone, alcohol alone and their joint effect. Tobacco and alcohol together explained 73% of UADT cancer burden of which nearly 29% was explained by smoking alone, less than 1% due to alcohol on its own and 44% by the joint effect of tobacco and alcohol. Tobacco and alcohol together explained a larger proportion of hypopharyngeal/laryngeal cancer (PAR = 85%) than oropharyngeal (PAR = 74%), esophageal (PAR = 67%) and oral cancer (PAR = 61%). Tobacco and alcohol together explain only about half of the total UADT cancer burden among women. Geographically, tobacco and alcohol explained a larger proportion of UADT cancer in central (PAR = 84%) than southern (PAR = 72%) and western Europe (PAR = 67%). While the majority of the UADT cancers in Europe are due to tobacco or the joint effect of tobacco and alcohol, our results support a significant role for other risk factors in particular, for oral and oropharyngeal cancers and also for UADT cancers in southern and western Europe. (C) 2011 Elsevier Ltd. All rights reserved.


Publication metadata

Author(s): Anantharaman D, Marron M, Lagiou P, Samoli E, Ahrens W, Pohlabeln H, Slamova A, Schejbalova M, Merletti F, Richiardi L, Kjaerheim K, Castellsague X, Agudo A, Talamini R, Barzan L, Macfarlane TV, Tickle M, Simonato L, Canova C, Conway DI, McKinney PA, Thomson P, Znaor A, Healy CM, McCartan BE, Hashibe M, Brennan P, Macfarlane GJ

Publication type: Article

Publication status: Published

Journal: Oral Oncology

Year: 2011

Volume: 47

Issue: 8

Pages: 725-731

Print publication date: 01/08/2011

ISSN (print): 1368-8375

ISSN (electronic): 1741-9409

Publisher: Pergamon

URL: http://dx.doi.org/10.1016/j.oraloncology.2011.05.004

DOI: 10.1016/j.oraloncology.2011.05.004


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
QLK1-2001-00182European commission

Share